British Patient Capital has committed $35m to The Evolution Technology Fund II. The Fund is expected to achieve a targeted $250m final close in the coming months and is already investing in growing cybersecurity and enterprise software companies.

Evolution Equity Partners has been investing in cybersecurity companies over the past 20 years, building global leaders over several economic cycles, including to IPO. Their strategy targets companies that are making use of big-data, machine learning, artificial intelligence, and SaaS.